PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
February 05, 2025 16:05 ET
|
PennantPark Floating Rate Capital Ltd.
MIAMI, Feb. 05, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for February 2025 of $0.1025 per share, payable on...
Allot to Release Fourth Quarter & Full Year 2024 Results and Host Conference Call on February 25, 2025
February 05, 2025 09:08 ET
|
Allot
Hod Hasharon, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network-native cybersecurity and network intelligence solutions...
Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
February 05, 2025 07:00 ET
|
Can-Fite BioPharma Ltd.
Ramat Gan, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...
SaverOne Announces New Deployment of Its Driver Distraction Prevention System in Teva Pharmaceutical’s Truck Fleet
February 04, 2025 09:12 ET
|
SaverOne 2014 Ltd.
Teva, a global pharmaceutical leader, to install the SaverOne System across its entire fleet of 50 delivery trucks in Israel Petah Tikvah, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014...
Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million
February 04, 2025 07:00 ET
|
Pluri Inc.
New investment follows recent private placement of $6.5 million with global investor and entrepreneur, Mr. Alejandro WeinsteinFunds are intended to support Pluri’s growth and execution strategy as a...
Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform
February 03, 2025 07:00 ET
|
Purple Biotech Ltd.
Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing tumor-specific immunity against multiple cancer...
Enlight to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 19, 2025
January 30, 2025 13:30 ET
|
Enlight Renewable Energy Ltd.
TEL AVIV, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Enlight Renewable Energy Ltd. (“Enlight”, “the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a leading global renewable energy platform, today announced...
SaverOne Announces $1.5 Million Registered Direct Offering
January 30, 2025 09:09 ET
|
SaverOne 2014 Ltd.
Petah Tikvah, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology leader in advanced transportation safety solutions, today announced that it has...
SaverOne to Deploy Driver Safety Systems Across Oz Group’s Fleet
January 30, 2025 09:00 ET
|
SaverOne 2014 Ltd.
100 SaverOne Systems will be installed in Oz Group Trucks and Cars Petah Tikvah, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a leading innovator in...
Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth
January 29, 2025 07:00 ET
|
Teva Pharmaceutical Industries Ltd
2024 Revenues of $16.5 billion reflect an increase of 6%, in local currency terms, compared to 2023;AUSTEDO® - exceeding $1.6 billion in revenues, surpassing 2024 outlook;AJOVY® - global annual...